Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 6/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | BACE1 | P56817 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | HCRTR1 | O43613 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.36 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.36 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15238832 | 0.88 | KDM4E (0.40) | L3MBTL1GLAMAPTKDM4EALDH1A1 | |
| SCHEMBL7175433 | 0.87 | KCNK3 (0.39) | L3MBTL1GLAMAPTKDM4EALDH1A1 | |
| SCHEMBL710804 | 0.85 | ABCB1 (0.44) | L3MBTL1MAPTALDH1A1HSD17B10KCNMA1 | |
| SCHEMBL4159840 | 0.84 | L3MBTL1 (0.37) | L3MBTL1GLAMAPTKDM4EALDH1A1 | |
| SCHEMBL155286 | 0.81 | IRAK4 (0.43) | KDM4EALDH1A1HPGDLMNAKCNK3 | |
| SCHEMBL3440188 | 0.79 | L3MBTL1 (0.50) | L3MBTL1GLAMAPTKDM4EALDH1A1 | |
| SCHEMBL7989562 | 0.77 | L3MBTL1 (0.40) | L3MBTL1GLAMAPTKDM4ETHRB | |
| SCHEMBL7189022 | 0.77 | HCRTR1 (0.40) | L3MBTL1GLAMAPTKDM4EALDH1A1 | |
| SCHEMBL15238854 | 0.76 | ABCB1 (0.39) | L3MBTL1MAPTKDM4EALDH1A1TP53 | |
| SCHEMBL7181297 | 0.75 | MAPT (0.37) | L3MBTL1GLAMAPTKDM4EKCNMA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 377 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024165880-A1 | UV-CURABLE INKJET INK, AND INKJET RECORDING METHOD | ａｒｔｉｅｎｃｅ株式会社 | 2024-08-15 | — | — | WO | claimed |
| CN-117986997-A | Photocurable conductive black composition and method for forming cured product thereof | 杜邦电子公司 | 2024-05-07 | — | — | CN | claimed |
| CN-110850678-B | Photosensitive compound, preparation method thereof, photosensitive compound composition and cured product thereof | 株式会社力森诺科 | 2024-03-15 | — | — | CN | claimed |
| US-11866593-B2 | Ultraviolet curable inkjet ink | TOYO INK SC HOLDINGS CO., LTD. (JP) | 2024-01-09 | — | — | US | claimed |
| CN-117089238-A | Sand-blasting-resistant printing ink for glass cover plate and preparation method thereof | 广州亦盛环保科技有限公司 | 2023-11-21 | — | — | CN | claimed |
| EP-4269513-A1 | ULTRAVIOLET RADIATION CURING TYPE INKJET INK | Toyo Ink SC Holdings Co., Ltd. (JP) | 2023-11-01 | — | — | EP | claimed |
| CN-114773906-B | Ink composition and preparation method and application thereof | 广州亦盛环保科技有限公司 | 2023-08-29 | — | — | CN | claimed |
| CN-113260332-B | Photocurable resin composition, photocurable resin product, and method for producing product | 加利福尼亚大学董事会 | 2023-04-07 | — | — | CN | claimed |
| US-20230002630-A1 | ULTRAVIOLET CURABLE INKJET INK | TOYO INK SC HOLDINGS CO., LTD. (JP) | 2023-01-05 | — | — | US | claimed |
| CN-113260332-A | Photocurable resin composition, photocurable resin product, and method for producing product | 加利福尼亚大学董事会 | 2021-08-13 | — | — | CN | claimed |
| CN-106054526-B | White active energy ray-curable resin composition, cured product thereof, and printed wiring board | 日本化药株式会社 | 2020-07-31 | — | — | CN | claimed |
| WO-2005075580-A1 | ULRAVIOLET RADIATION CURABLE CLEARCOAT COMPOSITION WITH LOW COLOR AND GOOD DURABILITY | BASF CORPORATION (US) | 2005-08-18 | — | — | WO | claimed |
| US-20050096427-A1 | Ultraviolet radiation curable clearcoat composition with low color and good durability | BASF AG, (DE) | 2005-05-05 | — | — | US | claimed |
| EP-4299321-B1 | ULTRAVIOLET CURABLE AQUEOUS INK COMPOSITION FOR INKJET PRINTING | SAKATA INX CORP (JP) | 2026-05-27 | — | — | EP | disclosed |
| EP-4737493-A1 | MODIFIED POLYOLEFIN RESIN COMPOSITION AND USE FOR SAID RESIN COMPOSITION | TOYOBO MC Corporation (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-12617961-B2 | UV-curable aqueous inkjet printing ink composition | SAKATA INX CORPORATION (JP) | 2026-05-05 | — | — | US | disclosed |
| US-6288136-B1 | Radiation curable resin composition for cast polymerization | DSM N.V. (NL) | 2001-09-11 | — | — | US | disclosed |
| US-6251963-B1 | ORGAOPHOSPHOROUS COMPOUND CONTAINING KETONE GROUP | CIBA SPECIALTY CHEMICALS CORPORATION | 2001-06-26 | — | — | US | disclosed |
| EP-1003796-A1 | RADIATION CURABLE RESIN COMPOSITITON FOR CAST POLYMERIZATION | DSM N.V. (NL) | 2000-05-31 | — | — | EP | disclosed |
| WO-1999007757-A1 | RADIATION CURABLE RESIN COMPOSITITON FOR CAST POLYMERIZATION | DSM N.V. (NL) | 1999-02-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12617961-B2 | UV-curable aqueous inkjet printing ink composition | WDR3, WDR1, WAPL | L3MBTL1 737/4885GLA 3898/4885MAPT 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.